Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
The implantable cardioverter-defibrillator (ICD) has become an integral part of treatment for a variety of patients with symptomatic, or at risk for, ventricular tachyarrhythmias. The ICD's effectiveness is attributed to its ability to promptly detect and terminate ventricular tachycardia (VT)...
Main Author: | Luis A. Pires |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-08-01
|
Series: | Indian Pacing and Electrophysiology Journal |
Subjects: | |
Online Access: | http://www.ipej.org/0703/pires.htm |
Similar Items
-
Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
by: Yasuhisa Nakao, et al.
Published: (2020-03-01) -
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01) -
Implantable cardioverter defibrillator in MC Ljubljana. An overview from 1989–2005
by: Igor Zupan, et al.
Published: (2005-12-01) -
Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
by: Naomichi Matsumoto, MD, et al.
Published: (2010-01-01) -
The Automatic External Cardioverter-Defibrillator
by: Antoni Martínez-Rubio, et al.
Published: (2004-07-01)